Shanghai Pharmaceuticals Holding Co Ltd Total Liabilities

Latest as of June 2026: CN¥147.98 Billion CNY ≈ $21.65 Billion USD

Shanghai Pharmaceuticals Holding Co Ltd total liabilities. Based on the latest financial reports, Shanghai Pharmaceuticals Holding Co Ltd (601607) has total liabilities worth CN¥147.98 Billion CNY (≈ $21.65 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 601607 financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Shanghai Pharmaceuticals Holding Co Ltd (1994–2025)

Total liabilities of Shanghai Pharmaceuticals Holding Co Ltd from 1994 to 2025. This chart illustrates how Shanghai Pharmaceuticals Holding Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 601607 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Shanghai Pharmaceuticals Holding Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shanghai Pharmaceuticals Holding Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Maha Properti Indonesia Tbk PT JK:MPRO	Indonesia	Rp485.51 Billion
HELLENIC TELEC.ORG.ADR1/2 F:OTES	Germany	€2.93 Billion
NINGBO SHANSHAN GDR/A F:OJ8	Germany	€22.34 Billion
Hyundai Heavy Industries Holdings Co Ltd KO:267250	Korea	₩53.43 Trillion
Gaztransport & Technigaz SAS PA:GTT	France	€353.99 Million
Open Text Corp TO:OTEX	Canada	CA$9.52 Billion
Arcellx Inc NASDAQ:ACLX	USA	$201.64 Million
Amdocs Ltd NASDAQ:DOX	USA	$2.88 Billion

Liability Composition Analysis (1994–2025)

This chart breaks down Shanghai Pharmaceuticals Holding Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Shanghai Pharmaceuticals Holding Co Ltd (601607) total assets.

Liquidity & Leverage Metrics

Shanghai Pharmaceuticals Holding Co Ltd Total Liabilities Ratios Explained

Shanghai Pharmaceuticals Holding Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.34	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.89	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.61	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Pharmaceuticals Holding Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Pharmaceuticals Holding Co Ltd (1994–2025)

The table below shows the annual total liabilities of Shanghai Pharmaceuticals Holding Co Ltd from 1994 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥143.36 Billion ≈ $20.98 Billion	+4.29%
2024-12-31	CN¥137.47 Billion ≈ $20.12 Billion	+4.42%
2023-12-31	CN¥131.65 Billion ≈ $19.26 Billion	+9.58%
2022-12-31	CN¥120.13 Billion ≈ $17.58 Billion	+15.10%
2021-12-31	CN¥104.37 Billion ≈ $15.27 Billion	+10.51%
2020-12-31	CN¥94.44 Billion ≈ $13.82 Billion	+7.76%
2019-12-31	CN¥87.64 Billion ≈ $12.82 Billion	+8.94%
2018-12-31	CN¥80.45 Billion ≈ $11.77 Billion	+47.15%
2017-12-31	CN¥54.67 Billion ≈ $8.00 Billion	+19.08%
2016-12-31	CN¥45.91 Billion ≈ $6.72 Billion	+13.25%
2015-12-31	CN¥40.54 Billion ≈ $5.93 Billion	+21.94%
2014-12-31	CN¥33.24 Billion ≈ $4.86 Billion	+21.72%
2013-12-31	CN¥27.31 Billion ≈ $4.00 Billion	+16.87%
2012-12-31	CN¥23.37 Billion ≈ $3.42 Billion	+7.76%
2011-12-31	CN¥21.69 Billion ≈ $3.17 Billion	+33.17%
2010-12-31	CN¥16.28 Billion ≈ $2.38 Billion	+157.08%
2009-12-31	CN¥6.33 Billion ≈ $926.94 Million	+11.80%
2008-12-31	CN¥5.67 Billion ≈ $829.08 Million	+9.65%
2007-12-31	CN¥5.17 Billion ≈ $756.14 Million	+12.05%
2006-12-31	CN¥4.61 Billion ≈ $674.83 Million	+5.53%
2005-12-31	CN¥4.37 Billion ≈ $639.50 Million	-0.75%
2004-12-31	CN¥4.40 Billion ≈ $644.31 Million	+9.33%
2003-12-31	CN¥4.03 Billion ≈ $589.33 Million	+18.34%
2002-12-31	CN¥3.40 Billion ≈ $498.00 Million	+37.51%
2001-12-31	CN¥2.47 Billion ≈ $362.16 Million	-2.94%
2000-12-31	CN¥2.55 Billion ≈ $373.14 Million	+15.61%
1999-12-31	CN¥2.21 Billion ≈ $322.77 Million	+16.23%
1998-12-31	CN¥1.90 Billion ≈ $277.71 Million	+518.28%
1997-12-31	CN¥306.95 Million ≈ $44.92 Million	-1.92%
1996-12-31	CN¥312.95 Million ≈ $45.79 Million	+17.26%
1995-12-31	CN¥266.88 Million ≈ $39.05 Million	+18.53%
1994-12-31	CN¥225.16 Million ≈ $32.95 Million	--

About Shanghai Pharmaceuticals Holding Co Ltd

SHG:601607 China Medical Distribution

Market Cap

$6.74 Billion

CN¥46.08 Billion CNY

Market Cap Rank

#2846 Global

#300 in China

Share Price

CN¥16.52

Change (1 day)

+0.55%

52-Week Range

CN¥15.29 - CN¥18.41

All Time High

CN¥25.03